Semaglutide is a GLP-1 receptor agonist peptide studied for its effects on insulin secretion, appetite regulation, and metabolic control. It has been examined in preclinical models for its potential to support glucose homeostasis and reduce food intake. Researchers continue to explore its mechanisms in weight and metabolic studies.
